Krebs Biochemicals & Industries Limited (BOM:524518)

India flag India · Delayed Price · Currency is INR
75.85
+3.10 (4.26%)
At close: Sep 10, 2025
4.26%
Market Cap1.67B
Revenue (ttm)359.04M
Net Income (ttm)-270.93M
Shares Out21.56M
EPS (ttm)-12.56
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume251
Average Volume701
Open75.00
Previous Close72.75
Day's Range74.83 - 76.38
52-Week Range63.55 - 129.00
Beta0.60
RSI54.20
Earnings DateNov 7, 2025

About BOM:524518

Krebs Biochemicals & Industries Limited engages in the manufacture and sale of active pharmaceutical ingredients in India. The company develops biotech processes for application in medicine, agriculture, and industry. Its products include androstenedione, lovastatin, and simvastatin, which are used for anti-cholesterol and steroid intermediate applications. The company also develops various products, including amlodipine, cetirizine, orlistat, serratiopepetidase, telmisartan, and phenylephrine for anti-hypertension, anti-histamine, anti-obesity... [Read more]

Industry Medicinal Chemicals and Botanical Products
Founded 1991
Employees 202
Stock Exchange Bombay Stock Exchange
Ticker Symbol 524518
Full Company Profile

Financial Performance

In 2024, BOM:524518's revenue was 433.12 million, a decrease of -14.10% compared to the previous year's 504.22 million. Losses were -269.39 million, 36.6% more than in 2023.

Financial Statements

News

Krebs Biochemicals & Industries halts production following order from Andhra Pradesh Pollution Control Board

Krebs Biochemicals & Industries Limited announced that it has been directed to immediately cease all production activities at its manufacturing unit located in Kothapalli (V), Kasimkota (M), Anakapall...

7 months ago - Business Upturn